LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | A443654 | 1.11 | uM | LJP6 | 0.1756 | 0.0326 | -0.1170 | 0.0516 |
| MDA-MB-231 | OSI-027 | 1.11 | uM | LJP6 | 0.7453 | 0.0120 | 0.6553 | 0.0129 |
| MDA-MB-231 | XMD11-85h | 1.11 | uM | LJP6 | 0.8398 | 0.0340 | 0.7834 | 0.0446 |
| MDA-MB-231 | HG-6-64-01 | 1.11 | uM | LJP6 | 0.4334 | 0.0608 | 0.2314 | 0.0893 |
| MDA-MB-231 | WH-4-025 | 1.11 | uM | LJP5 | 0.2428 | 0.0379 | -0.0258 | 0.0548 |
| MDA-MB-231 | WZ-4-145 | 1.11 | uM | LJP6 | 0.7597 | 0.0550 | 0.6737 | 0.0769 |
| MDA-MB-231 | XMD16-144 | 1.11 | uM | LJP5 | 0.3311 | 0.0245 | 0.0934 | 0.0419 |
| MDA-MB-231 | Brivanib | 1.11 | uM | LJP5 | 0.9372 | 0.0425 | 0.9156 | 0.0566 |
| MDA-MB-231 | Buparlisib | 1.11 | uM | LJP5 | 0.5687 | 0.0397 | 0.4169 | 0.0485 |
| MDA-MB-231 | BX-912 | 1.11 | uM | LJP5 | 0.5144 | 0.0851 | 0.3410 | 0.1203 |
| MDA-MB-231 | Canertinib | 1.11 | uM | LJP6 | 0.7972 | 0.0171 | 0.7250 | 0.0254 |
| MDA-MB-231 | Celastrol | 1.11 | uM | LJP6 | 0.3121 | 0.0937 | 0.0679 | 0.1294 |
| MDA-MB-231 | CGP60474 | 1.11 | uM | LJP5 | 0.1431 | 0.0290 | -0.1613 | 0.0505 |
| MDA-MB-231 | CGP60474 | 1.11 | uM | LJP6 | 0.1300 | 0.0296 | -0.1790 | 0.0515 |
| MDA-MB-231 | CHIR-99021 | 1.11 | uM | LJP6 | 0.8351 | 0.0296 | 0.7762 | 0.0415 |
| MDA-MB-231 | CP724714 | 1.11 | uM | LJP5 | 0.9242 | 0.0620 | 0.8989 | 0.0827 |
| MDA-MB-231 | CP466722 | 1.11 | uM | LJP5 | 0.9474 | 0.0183 | 0.9287 | 0.0250 |
| MDA-MB-231 | Crizotinib | 1.11 | uM | LJP5 | 0.5892 | 0.0892 | 0.4435 | 0.1216 |
| MDA-MB-231 | Momelotinib | 1.11 | uM | LJP5 | 0.6015 | 0.0678 | 0.4588 | 0.0969 |
| MDA-MB-231 | Dasatinib | 1.11 | uM | LJP5 | 0.1590 | 0.0153 | -0.1390 | 0.0232 |
| MDA-MB-231 | Dasatinib | 1.11 | uM | LJP6 | 0.1558 | 0.0096 | -0.1433 | 0.0170 |
| MDA-MB-231 | Dovitinib | 1.11 | uM | LJP5 | 0.5422 | 0.0488 | 0.3798 | 0.0672 |
| MDA-MB-231 | Enzastaurin | 1.11 | uM | LJP5 | 1.0118 | 0.0414 | 1.0165 | 0.0566 |
| MDA-MB-231 | Erlotinib | 1.11 | uM | LJP5 | 0.9718 | 0.0142 | 0.9618 | 0.0192 |
| MDA-MB-231 | Foretinib | 1.11 | uM | LJP5 | 0.3231 | 0.0309 | 0.0826 | 0.0484 |